Deutsch
Français
Italiano
Español
Svenska
Português
日本人
Dansk
Norsk
Suomi
Czech
Adimod (Pidotimod)
Active Ingredient: Pidotimod
Dosage: 400 mg
Route of Administration: Oral
Dosage Form: Tablets
Quantity per package: 20 pills
Availability: Out of stock
Why is Adimod not used in the USA?
Adimod is not used in the USA primarily because it has not been approved by the U.S. Food and Drug Administration (FDA). The FDA requires rigorous clinical trials to demonstrate a drug’s efficacy and safety before it can be marketed in the United States. Pidotimod might not have undergone such trials in the U.S. or failed to meet the necessary criteria for approval.
What are similar drugs sold in the USA as analogs to Adimod?
Here are similar drugs available in the USA, categorized based on their primary use or the diseases and symptoms they are prescribed for. These drugs, like Adimod, are used to manage immune response or treat infections but may vary in mechanism:
For Bacterial Infections:
A penicillin antibiotic used to treat a wide variety of bacterial infections.
$2,80 per pill
A fluoroquinolone antibiotic effective against various bacterial infections, particularly those of the urinary tract and digestive system.
$1,79 per pill
A macrolide antibiotic used for treating a range of bacterial infections, including respiratory and skin infections.
$0,41 per pill
For Viral Infections:
An antiviral drug used primarily to treat herpes simplex and varicella zoster viruses.
$0,46 per pill
An antiviral medication that helps manage herpes virus infections, including shingles and genital herpes.
$1,81 per pill
Immunomodulatory Drugs:
Used primarily to treat certain cancers and sickle cell disease, it also has effects on the immune system.
$1,36 per pill
For Respiratory Infections:
Combines amoxicillin with clavulanate, a beta-lactamase inhibitor, to treat bacterial infections resistant to other antibiotics.
$1,67 per pill
A tetracycline antibiotic used to treat a variety of infections, including respiratory tract infections and Lyme disease.
$0,94 per pill
What is Adimod?
Adimod (pidotimod) is an immunomodulatory medication. It stimulates the human immune system to different viruses and bacteria. The latest clinical trials have shown this drug obtains an immunomodulatory activity. It is able both to improve the clinical conditions of patients and to enhance and stimulate their immunity cells.
Indications
Adimod has an immunostimulatory and immunoregulatory activity on T lymphocytes, it is indicated in problems of secondary and primary immunity with impaired maturation of T lymphocytes, in respiratory system infections.
Dosage and administration
For oral use.
Acute phase: Dose in adults: Take 2 tablets of 400 mg or 1 tablet of 800 mg, twice a day, two hours before or two hours after meals and for 15 days. Dose in the elderly and children: Take 1 tablet of 400 mg, twice a day, two hours before or two hours after meals and for 15 days. Prophylactic phase: Dose in adults: Take 2 tablets of 400 mg or 1 tablet of 800 mg, once a day, two hours before or two hours after meals and for 60 days. Elderly and children: Take 1 tablet of 400 mg, once a day, two hours before or two hours after meals and for 60 days.
Contraindications
Adimod should not be used simultaneously with immunosuppressive treatment or in patients with known hypersensitivity to the product.
Side effects
This drug is generally well tolerated but it may cause diarrhea in rare cases.
Overdose
There are no data on overdose when administered at doses higher than those recommended. However, the use of the drug at high doses can cause sedation, ataxia, dyspnea, and cyanosis. Treatment: gastric lavage, use activated carbon, supportive measures.
Interaction
Adimod does not interfere with the use of antibiotics or modify the side effects caused by them. It can interact with those medications that block or stimulate lymphocyte activity, such as thyreostimuline. It can also interfere with those mechanisms that are somehow connected to the IGE. The intake of this drug with food causes a delay in the absorption of the drug and the reduction of its bioavailability to 50%.